FDA
FDA issues five year drug import debarment
FDA issued a final order debarring Sanjay Kumar for five years from importing or offering to import any drug into the United States. The order follows a federal felony conviction for conspiracy to traffic in counterfeit goods.
Read the official sourceMHRA
MHRA publishes latest Field Safety Notices
MHRA posted its list of Field Safety Notices covering 14 to 18 September 2026.
Read the official sourceMHRA
MHRA updates regulatory performance data
MHRA published key performance indicator data and information on expected timelines for completing specific regulatory functions.
Read the official sourceWhy this matters
The FDA order illustrates the use of import debarment following conduct involving counterfeit drugs. The MHRA publications give regulatory teams current references for device safety activity and expected agency processing timelines.
Scott Morvay
Founder, Gulfstream Intelligence
This brief provides general regulatory news and educational information. It is not legal or regulatory advice.